{"issuance_frequency":"","notes_translated":{"fr":"Le présent guide est destiné aux entreprises dans l'industrie du médicament. Il vise à faciliter la compréhension et la conformité envers la partie C, titre 1A, du Règlement sur les aliments et drogues (RAD) en ce qui concerne les exigences relatives à la licence d'établissement pour les produits pharmaceutiques (LEPP).","en":"This guide is for companies in the drug manufacturing industry. It will help to facilitate understanding and compliance with Part C, Division 1A of the Food and Drug Regulations (FDR) with regards to drug establishment licence (DEL) requirements."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"f4c2146c-3a8e-4213-a589-f1e59965926f","metadata_created":"2021-04-26T19:31:13.982293","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-04-26T19:31:13.982300","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-04-26","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Conseils","industrie de la fabrication de médicaments","licences d'établissement de médicaments","GUI-0002","conditions de licence"],"en":["Guidance","drug manufacturing industry","Drug Establishment Licences","GUI-0002","licence requirements"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Document d'orientation sur les licences d'établissement de produits pharmaceutiques (GUI-0002)","en":"Guidance on Drug Establishment Licences (GUI-0002)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"f4c2146c-3a8e-4213-a589-f1e59965926f","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4193cacd-a9a3-4ff3-96ec-8a404db618d5","related_relationship":"","name_translated":{"fr":"Document d'orientation sur les licences d'établissement de produits pharmaceutiques (GUI-0002)","en":"Guidance on Drug Establishment Licences (GUI-0002)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance on Drug Establishment Licences (GUI-0002)","language":["en"],"created":"2021-04-26T19:31:14.135108","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/guidance-drug-establishment-licences-drug-establishment-licensing-fees-0002/document.html","last_modified":null,"position":0,"revision_id":"603bc3cb-915f-45a6-8ed6-c3c3bc1e4f80","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"f4c2146c-3a8e-4213-a589-f1e59965926f","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d420abc8-83be-4025-90c0-a8fcaaf884c5","related_relationship":"","name_translated":{"fr":"Document d'orientation sur les licences d'établissement de produits pharmaceutiques (GUI-0002)","en":"Guidance on Drug Establishment Licences (GUI-0002)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance on Drug Establishment Licences (GUI-0002)","language":["fr"],"created":"2021-04-26T19:31:14.135115","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/licences-etablissement/directives-documents-orientation-politiques/document-orientation-licences-etablissement-prix-payer-licences-etablissement-0002/document.html","last_modified":null,"position":1,"revision_id":"603bc3cb-915f-45a6-8ed6-c3c3bc1e4f80","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-12-21 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"f4c2146c-3a8e-4213-a589-f1e59965926f","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This guide is for companies in the drug manufacturing industry. It will help to facilitate understanding and compliance with Part C, Division 1A of the Food and Drug Regulations (FDR) with regards to drug establishment licence (DEL) requirements.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance on Drug Establishment Licences (GUI-0002)","revision_id":"603bc3cb-915f-45a6-8ed6-c3c3bc1e4f80"}